ebook Munafa Stock Market Course + Intraday & FNO calls  

       

AkebiaTherapeutics AKBA full analysis,charts,indicators,moving averages,SMA,DMA,EMA,ADX,MACD,RSI

Akebia Therapeutics AKBA WideScreen charts, DMA,SMA,EMA technical analysis, forecast prediction, by indicators ADX,MACD,RSI,CCI USA stock exchange

operates under Health Care sector & deals in Major Pharmaceuticals

Daily price and charts and targets AkebiaTherapeutics

Strong intraday Stock price targets for AkebiaTherapeutics are 1.39 and 1.43

Intraday Target 11.38
Intraday Target 21.4
Intraday Target 31.4233333333333
Intraday Target 41.44
Intraday Target 51.46

Daily price and volume Akebia Therapeutics

Date Closing Open Range Volume
Thu 09 April 2026 1.41 (-1.4%) 1.42 1.41 - 1.45 0.6027 times
Wed 08 April 2026 1.43 (3.62%) 1.41 1.40 - 1.47 1.188 times
Tue 07 April 2026 1.38 (4.55%) 1.32 1.30 - 1.39 1.1083 times
Mon 06 April 2026 1.32 (-4.35%) 1.37 1.32 - 1.40 1.1118 times
Thu 02 April 2026 1.38 (-2.13%) 1.39 1.36 - 1.40 0.8846 times
Wed 01 April 2026 1.41 (1.44%) 1.40 1.40 - 1.46 0.8725 times
Tue 31 March 2026 1.39 (5.3%) 1.34 1.34 - 1.40 0.8934 times
Mon 30 March 2026 1.32 (-1.49%) 1.34 1.30 - 1.36 1.2424 times
Fri 27 March 2026 1.34 (-3.6%) 1.37 1.32 - 1.38 1.2403 times
Thu 26 March 2026 1.39 (0%) 1.39 1.36 - 1.44 0.856 times
Wed 25 March 2026 1.39 (2.21%) 1.40 1.36 - 1.42 0.8873 times

 Daily chart AkebiaTherapeutics

Weekly price and charts AkebiaTherapeutics

Strong weekly Stock price targets for AkebiaTherapeutics AKBA are 1.36 and 1.53

Weekly Target 11.22
Weekly Target 21.32
Weekly Target 31.3933333333333
Weekly Target 41.49
Weekly Target 51.56

Weekly price and volumes for Akebia Therapeutics

Date Closing Open Range Volume
Thu 09 April 2026 1.41 (2.17%) 1.37 1.30 - 1.47 0.6704 times
Thu 02 April 2026 1.38 (2.99%) 1.34 1.30 - 1.46 0.6507 times
Fri 27 March 2026 1.34 (-4.96%) 1.43 1.32 - 1.45 0.8414 times
Fri 20 March 2026 1.41 (-3.42%) 1.48 1.39 - 1.56 0.7124 times
Fri 13 March 2026 1.46 (14.06%) 1.26 1.25 - 1.52 0.8929 times
Fri 06 March 2026 1.28 (-2.29%) 1.27 1.18 - 1.30 1.0731 times
Fri 27 February 2026 1.31 (11.02%) 1.19 1.18 - 1.51 1.565 times
Fri 20 February 2026 1.18 (-2.48%) 1.21 1.14 - 1.24 0.8876 times
Fri 13 February 2026 1.21 (0%) 1.35 1.20 - 1.37 0.4746 times
Fri 13 February 2026 1.21 (-12.95%) 1.37 1.20 - 1.60 2.2319 times
Fri 06 February 2026 1.39 (-2.11%) 1.39 1.33 - 1.44 1.2484 times

 weekly chart AkebiaTherapeutics

Monthly price and charts AkebiaTherapeutics

Strong monthly Stock price targets for AkebiaTherapeutics AKBA are 1.36 and 1.53

Monthly Target 11.22
Monthly Target 21.32
Monthly Target 31.3933333333333
Monthly Target 41.49
Monthly Target 51.56

Monthly price and volumes Akebia Therapeutics

Date Closing Open Range Volume
Thu 09 April 2026 1.41 (1.44%) 1.40 1.30 - 1.47 0.1789 times
Tue 31 March 2026 1.39 (6.11%) 1.27 1.18 - 1.56 0.7192 times
Fri 27 February 2026 1.31 (-7.75%) 1.39 1.14 - 1.60 1.1888 times
Fri 30 January 2026 1.42 (-11.8%) 1.63 1.30 - 1.63 0.8033 times
Wed 31 December 2025 1.61 (1.9%) 1.60 1.45 - 1.73 0.9131 times
Fri 28 November 2025 1.58 (-28.51%) 2.10 1.49 - 2.15 1.304 times
Fri 31 October 2025 2.21 (-19.05%) 2.72 2.07 - 3.20 1.4841 times
Tue 30 September 2025 2.73 (-13.06%) 3.07 2.66 - 3.22 1.0793 times
Fri 29 August 2025 3.14 (-14.91%) 3.65 2.92 - 3.79 1.2896 times
Thu 31 July 2025 3.69 (1.37%) 3.63 3.47 - 4.08 1.0398 times
Mon 30 June 2025 3.64 (20.13%) 3.06 2.97 - 4.08 1.8163 times

 monthly chart AkebiaTherapeutics

Yearly price and charts AkebiaTherapeutics

Strong yearly Stock price targets for AkebiaTherapeutics AKBA are 1.03 and 1.52

Yearly Target 10.9
Yearly Target 21.16
Yearly Target 31.3933333333333
Yearly Target 41.65
Yearly Target 51.88

Yearly price and volumes Akebia Therapeutics

Date Closing Open Range Volume
Thu 09 April 2026 1.41 (-12.42%) 1.63 1.14 - 1.63 0.2531 times
Wed 31 December 2025 1.61 (-15.26%) 1.90 1.45 - 4.08 1.278 times
Tue 31 December 2024 1.90 (53.23%) 1.22 0.80 - 2.48 0.9535 times
Fri 29 December 2023 1.24 (117.54%) 0.58 0.49 - 1.84 0.5809 times
Fri 30 December 2022 0.57 (-74.78%) 2.28 0.24 - 2.93 2.1552 times
Fri 31 December 2021 2.26 (-19.29%) 2.83 2.20 - 5.14 1.2905 times
Thu 31 December 2020 2.80 (0%) 2.71 2.09 - 4.18 0.4889 times
Fri 10 April 2026 (0%) - 0 times

Indicator Analysis of AkebiaTherapeutics

Tomorrow's movement Prediction of Akebia Therapeutics AKBA appears to be in uptrend. And this trend seems to be continuing further.

Price is above an important level of 1.38 on charts, and as long as price remains above this level, the uptrend of stock might continue.

Tomorrow's movement Prediction of Akebia Therapeutics AKBA made a big move recently. This generally happens when there is a positive sentiment change, or a block deal went through. There is a good chance that this trend might continue in coming days.

Tomorrow's movement Prediction of Akebia Therapeutics AKBA is strongly bearish. It has broken a strong support of 2 and is expected to move down further.

Munafa value: 60 as on Thu 09 April 2026

This Munafa value indicates that the stock is moving sideways and there is no definite momentum in the stock.

SMA20 is at 2 and price is deviating by 1 points

Upper Bollinger band is at 2 and lower is at 2, while middle bands are at 2 and 2

Price is coming down

Price is above 20day SMA

Price is in lower range of bands

Price action analysis of AkebiaTherapeutics (AKBA) based on a short term time period is positive, but buyers have become active on the stock recently. This cannot be a definite uptrend, specially if selected time duration is small.

ADX buy sell signal for AkebiaTherapeutics stock for short term is SELL. Signal strength is Weak and stock is losing momentum.

MACD generated a SELL signal for AkebiaTherapeutics in short term

AkebiaTherapeutics Stock in short term is moving inside a range for now. Please check in a day or two to for a better buy sell signal. Bulls are getting stronger in this stock.

Ichimoku cloud is of green color and prices are above the green cloud Prices appear to be coming down

CCI has generated a SELL signal for AkebiaTherapeutics in short term but SELL signal is weak.

RSI is generating a BUY signal in short term and the buying is gaining momentum.

MRSI is in negative zone. This is the SELL zone

Although the stock is in the SELL zone, but selling might be slowing down

Stock of AkebiaTherapeutics is picking up selling momentum according to indicator.

Volume based indicators are showing selling momentum.

Volume Weighted Averaged Price (VWAP) for short term is 1.37 and AkebiaTherapeutics AKBA stock is trading above this level. This is a good sign for the stock and it could move higher. VWAP is falling down

People seem to be coming out and selling the AkebiaTherapeutics AKBA stock. Volume based technical analysis of AkebiaTherapeutics AKBA stock is negative.

AkebiaTherapeutics Stock is giving positive returns over a short term period. Returns for a longer term period have been positive

Force Index is moving in a negative zone, which indicates selling momentum for short term... Selling momentum is getting weaker.

DMA SMA EMA moving averages of Akebia Therapeutics AKBA

DMA (daily moving average) of Akebia Therapeutics AKBA

DMA period DMA value
5 day DMA 1.38
12 day DMA 1.38
20 day DMA 1.4
35 day DMA 1.33
50 day DMA 1.35
100 day DMA 1.46
150 day DMA 1.88
200 day DMA 2.29

EMA (exponential moving average) of Akebia Therapeutics AKBA

EMA period EMA current EMA prev EMA prev2
5 day EMA1.41.391.37
12 day EMA1.381.381.37
20 day EMA1.371.371.36
35 day EMA1.361.361.36
50 day EMA1.351.351.35

SMA (simple moving average) of Akebia Therapeutics AKBA

SMA period SMA current SMA prev SMA prev2
5 day SMA1.381.381.38
12 day SMA1.381.381.37
20 day SMA1.41.41.39
35 day SMA1.331.331.32
50 day SMA1.351.351.35
100 day SMA1.461.461.46
150 day SMA1.881.891.91
200 day SMA2.292.312.32

Videos related to: AkebiaTherapeutics AKBA full analysis,charts,indicators,moving averages,SMA,DMA,EMA,ADX,MACD,RSI

Hindi Video What Is Needed To Succeed In Stock Markets

AkebiaTherapeutics AKBA full analysis,charts,indicators,moving averages,SMA,DMA,EMA,ADX,MACD,RSI

 

Back to top